Novo Nordisk: share buybacks continue
The Danish biopharmaceutical group says these acquisitions are part of its program to buy back up to 2.2 billion kroner worth of 'B' shares between May 7 and August 5.
With these operations, Novo says it now holds more than 10.5 million 'B' shares in treasury, representing around 0.2% of its capital.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction